A carregar...
Will availability of inhaled human insulin (Exubera(®)) improve management of type 2 diabetes? The design of the Real World trial
BACKGROUND: Common deterrents to insulin therapy for both physicians and patients are the complexity and burden of daily injections. In January 2006, the first inhaled human insulin (INH, Exubera(® )(insulinhuman [rDNA origin])InhalationPowder) was approved for use in adult patients with type 1 diab...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2006
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1564148/ https://ncbi.nlm.nih.gov/pubmed/16901335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-7-25 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|